Clin2
NCT07710846Possibly a fitNot yet recruiting

Cat and/or Birch Allergy Study

Conjunctivitis Allergic

Part of Eyes & vision, Immune system & allergy clinical trials.

This study is looking for adults and children aged 5 and older who have allergies to cats (Part A) and/or birch pollen (Part B). The goal is to better understand these allergies. If you are allergic to cats, you must not currently live with a cat and must not have lived with one in the past year.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,500 people
Ages
5 years and older
Study type
Observational

Who can take part

  • You must be 5 years old or older and weigh at least 10 kg (about 22 pounds).
  • You must have a history of allergic reactions to cats (Part A) and/or birch pollen (Part B).
  • You must have a positive skin prick test for cat or birch allergen at the screening visit.
  • If you are in Part A (cat allergy), you cannot currently live with a cat or have lived with one in the past year.
  • You must be willing and able to attend all clinic visits and complete the study assessments.
  • You cannot have any eye disease or condition that could affect the study, or a history of life-threatening asthma.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07171307Not yet recruiting
Immune cells in allergic conjunctivitis and allergy shots

This study looks at how immune cells work in people with allergic conjunctivitis and whether allergy shots (desensitization therapy) can help. It aims to understand the balance of certain immune cells in your eyes and blood.

Mexico City, Mexico City
NCT07675811Recruiting· Phase 3
Study of a new treatment for cat allergy related eye symptoms

This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.

Andover, Massachusetts
NCT07309432Recruiting· Phase 3
Birch allergy shot study for eye symptoms

This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.

Andover, Massachusetts
NCT05042830Recruiting
Tests how birch allergy in the nose affects allergy signals in blood

This study looks at people with a birch pollen allergy to see how exposure in the nose can change allergy-related blood signals. The results may help explain why symptoms can “boost” throughout the body after nasal allergen contact.

Vienna, State of Vienna
NCT07447869Recruiting· Early Phase 1
Lymph Node Exam in Cat Allergy Treatment Study

This study looks at lymph nodes in the neck to understand how the body responds to cat allergy treatments. It may help researchers improve allergy shots or other therapies for people with cat allergies.

Boston, Massachusetts
NCT00595491Recruiting· Phase 1
Study immune targets in cat and dust-mite allergic airway inflammation

This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.

Boston, Massachusetts

Hear when a new Conjunctivitis Allergic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.